Evidence map›Paper›PMID 41396122›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025

Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units.

Joel Francesqui, Mariana Benegas, Elena Laserna, Leticia Valera, Sandra Cuerpo, Fernanda Hernández-González, Mario Serrano, Marcelo Sánchez, Jacobo Sellares

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joel FrancesquiIR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Pulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain.ORCID 0000-0001-7106-3218
Mariana Benegas3Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Radiology Department, Hospital Clínic, Barcelona, Spain.
Elena LasernaPulmonology Department, Hospital de Mollet, Barcelona, Spain.
Leticia ValeraPulmonology Department, Hospital de Mollet, Barcelona, Spain.
Sandra CuerpoPulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain.
Fernanda Hernández-GonzálezPulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain; Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG).
Mario SerranoPulmonology Department, Hospital de Mollet, Barcelona, Spain.
Marcelo SánchezInterstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Radiology Department, Hospital Clínic, Barcelona, Spain.
Jacobo SellaresPulmonology Department, Respiratory Institute, Hospital Clínic, Barcelona, Spain; Interstitial Lung Diseases Core member, European Reference Networks (ERN-LUNG); Centro de Investigación Biomédica en Red Enfermedades Respiratorias.ORCID 0000-0001-6047-1670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

.

Identifiers

PMID41396122
PMCPMC12815284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.